\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes EICFor the European Innovation Council (EIC) Pathfinder Challenges 2023 call a number of 368 proposals were evaluated and 43 selected for funding. The five challenges were:
Among the successful projects are two consortia with a Flemish coordinator.
More info on the EIC Pathfinder scheme, the Pathfinder Challenges 2023 call statistics and an overview of all funded projects is available in the EIC news article
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Climate, Energy, Mobility Agro-Food, Environment EIT
The EIT (European Institute of Innovation and Technology) wants the three corners of the knowledge triangle to join forces to create succesful businesses. They consist of ten knowledge and innovation communities (KIC) each focussing on a specific sector. The KIC on Climate previously launched the 'Green Horizons farmers network', which foste... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
